Matthew Bashton

Cited by

	All	Since 2019
Citations	21598	20391
h-index	53	50
i10-index	114	111

8000

4000

2000

6000

2008200920102011201220132014201520162017201820192020202120222023202459 97 79 62 83 99 95 87 102 105 103 103 266 5718 7723 5246 1166

Public access

View all

149 articles

2 articles

available

not available

Based on funding mandates

Co-authors

David L RobertsonProfessor, CVR Bioinformatics, MRC-University of Glasgow Centre for Virus ResearchVerified email at glasgow.ac.uk
Sharon J PeacockUniversity of CambridgeVerified email at medschl.cam.ac.uk
Ben JacksonPostdoc, University of EdinburghVerified email at ed.ac.uk
Andrew RambautProfessor of Molecular Evolution, University of EdinburghVerified email at ed.ac.uk
Emma ThomsonProfessor of Infectious DiseasesVerified email at doctors.org.uk
Ravindra Kumar GuptaUniversity of CambridgeVerified email at cam.ac.uk
William T HarveyThe Roslin Institute, University of EdinburghVerified email at exseed.ed.ac.uk
Ewan M HarrisonWellcome Sanger InstituteVerified email at sanger.ac.uk
Thomas ConnorProfessor, Cardiff UniversityVerified email at cardiff.ac.uk
Christine J HarrisonNewcastle UniversityVerified email at newcastle.ac.uk
Anthony MoormanProfessor of Genetic Epidemiology, Newcastle UniversityVerified email at newcastle.ac.uk
Janet M ThorntonSenior Scientist, European Molecular Biology Laboratory - European Institute of Bioinformatics (EMBLVerified email at ebi.ac.uk
Christine VogelNew York University, Center for Genomics and Systems Biology, Dept. of BiologyVerified email at nyu.edu
Sarah A. TeichmannWellcome Sanger Institute & University of CambridgeVerified email at cam.ac.uk
Amir EnshaeiBloodwise /14M Genomics Integrative Biology FellowVerified email at newcastle.ac.uk
Nicola KerrisonMRC Epidemiology UnitVerified email at mrc-epid.cam.ac.uk
Prof. Julian GoughMRC Laboratory of Molecular Biology, CambridgeVerified email at mrc-lmb.cam.ac.uk
Carlo BerzuiniResearch Professor of Biostatistics, University of Manchester, UKVerified email at manchester.ac.uk
S. Asad RahmanBioInception LabsVerified email at bioinceptionlabs.com
Gemma L. HollidayAstraZenecaVerified email at astrazeneca.com

Matthew Bashton

The Hub for Biotechnology in the Built Environment, Faculty of Health and Life Sciences, Northumbria

Verified email at northumbria.ac.uk - Homepage

Bioinformatics Genomics Cancer Genomics Protein Structure and Evolution Protein Domains


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
SARS-CoV-2 variants, spike mutations and immune escape WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ... Nature Reviews Microbiology 19 (7), 409-424, 2021	3055	2021
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ... Science 372 (6538), eabg3055, 2021	2485	2021
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021	1079	2021
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The lancet 399 (10332), 1303-1312, 2022	1060	2022
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021	1055	2021
SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021	910	2021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022	797	2022
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021	732	2021
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021	690	2021
Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... MedRxiv, 2020.12. 30.20249034, 2021	603	2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021	557	2021
Structure, function and evolution of multidomain proteins C Vogel, M Bashton, ND Kerrison, C Chothia, SA Teichmann Current opinion in structural biology 14 (2), 208-216, 2004	480	2004
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021	423	2021
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ... Nature microbiology 7 (8), 1161-1179, 2022	396	2022
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK L Du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ... Science 371 (6530), 708-712, 2021	367	2021
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021	336	2021
SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021	293	2021
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020	255	2020
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages DP Martin, S Weaver, H Tegally, JE San, SD Shank, E Wilkinson, ... Cell 184 (20), 5189-5200. e7, 2021	250	2021
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70 SA Kemp, B Meng, IA Ferriera, R Datir, WT Harvey, G Papa, S Lytras, ... BioRxiv, 2020.12. 14.422555, 2020	245	2020

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors